Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): A systematic review and meta-analysis

BMJ Open

Volumn 5, Issue 9, 2015, Pages

  Rothnie, Kieran J ^a,b   Yan, Ruoling ^c   Smeeth, Liam ^b   Quint, Jennifer K ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR EFFECT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; DEATH; DISEASE EXACERBATION; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEART INFARCTION; HOSPITAL DISCHARGE; HUMAN; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; SMOKING; SYSTEMATIC REVIEW; COMORBIDITY; COMPLICATION; DISEASE COURSE; HEALTH SURVEY; META ANALYSIS; MORTALITY; MYOCARDIAL INFARCTION; OBSERVATIONAL STUDY; PROCEDURES; RISK FACTOR;

COMORBIDITY; DISEASE PROGRESSION; HUMANS; MYOCARDIAL INFARCTION; OBSERVATIONAL STUDIES AS TOPIC; POPULATION SURVEILLANCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS;

EID: 84947920916     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2015-007824     Document Type: Review

References (33)

1. Sin DD, Anthonisen NR, Soriano JB, et al. Mortality in COPD: role of comorbidities. Eur Respir J. 2006; 28: 1245-57.
2. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2006; 16: 63-70.
3. Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD, and incidence of myocardial infarction, and stroke: a comprehensive analysis using data from primary care. Thorax. 2010; 65: 956-62.
4. Schneider C, Bothner U, Jick SS, et al. Chronic obstructive pulmonary disease, and the risk of cardiovascular diseases. Eur J Epidemiol. 2010; 25: 253-60.
5. Divo M, Cote C, de Torres JP, et al. Comorbidities, and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012; 186: 155-61.
6. Mannino DM, Thorn D, Swensen A, et al. Prevalence, and outcomes of diabetes, hypertension, and cardiovascular disease in COPD. Eur Respir J. 2008; 32: 962-9.
7. Pitta F, Troosters T, Spruit MA, et al. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 171: 972-7.
8. Sin DD, Wu L, Man SF. The relationship between reduced lung function, and cardiovascular mortality: a population-based study, and a systematic review of the literature. Chest. 2005; 127: 1952-9.
9. Donaldson GC, Hurst JR, Smith CJ, et al. Increased risk of myocardial infarction, and stroke following exacerbation of COPD. Chest. 2010; 137: 1091-7.
10. Andell P, Koul S, Martinsson A, et al. Impact of chronic obstructive pulmonary disease on morbidity, and mortality after myocardial infarction. Open Heart. 2014; 1: e000002.
11. Enriquez JR, de Lemos JA, Parikh SV, et al. Association of chronic lung disease with treatments, and outcomes patients with acute myocardial infarction. Am Heart J. 2013; 165: 43-9.
12. Raposeiras Roubin S, Abu Assi E, Alvarez Alvarez B, et al. In-hospital, and follow-up mortality associated to chronic obstructive pulmonary disease in a contemporary cohort of patients with acute coronary syndrome. Eur Heart J. 2012; 33: 1084
13. Kjoller E, Kober L, Iversen K, et al. Importance of chronic obstructive pulmonary disease for prognosis, and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail. 2004; 6: 71-7.
14. Stefan MS, Bannuru RR, Lessard D, et al. The impact of COPD on management, and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest. 2012; 141: 1441-8.
15. Hadi HA, Zubaid M, Al Mahmeed W, et al. Prevalence, and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome. Clin Cardiol. 2010; 33: 228-35.
16. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. Secondary The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-Analyses. http://www.ohri.ca/programs/clinicalfiepidemiology/oxford.asp
17. Jüni P, Witschi A, Bloch R, et al. The hazards of scoring the quality of clinical trials for meta-Analysis. JAMA. 1999; 282: 1054-60.
18. Higgins J, Green S. Cochrane handbook for systematic reviews of interventions. Chichester, UK: John Wiley & Sons Ltd, 2008.
19. Rodriguez LA, Wallander MA, Martin-Merino E, et al. Heart failure, myocardial infarction, lung cancer, and death in COPD patients: a UK primary care study. Respir Med. 2010; 104: 1691-9.
20. Huiart L, Ernst P, Suissa S. Cardiovascular morbidity, and mortality in COPD. Chest. 2005; 128: 2640-6.
21. Halpin DM, Decramer M, Celli B, et al. Risk of nonlower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT Trial. Lung. 2011; 189: 261-8.
22. Behar S, Panosh A, Reicher-Reiss H, et al. Prevalence, and prognosis of chronic obstructive pulmonary disease among 5, 839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am J Med. 1992; 93: 637-41.
23. Bursi F, Vassallo R, Weston SA, et al. Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J. 2010; 160: 95-101.
24. Dziewierz A, Siudak Z, Rakowski T, et al. Relationship between chronic obstructive pulmonary disease, and in-hospital management, and outcomes in patients with acute myocardial infarction. Kardiol Pol. 2010; 68: 294-301.
25. Hawkins NM, Huang Z, Pieper KS, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur J Heart Fail. 2009; 11: 292-8.
26. Quint JK, Herrett E, Timmis A, et al. Survival after the first myocardial infarction is shorter in patients with COPD compared to the general population. Thorax. 2011; 66: A45-6.
27. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol. 2007; 99: 636-41.
28. Mapel DW, Dedrick D, Davis K. Trends, and cardiovascular co-morbidities of COPD patients in the veterans administration medical system, 1991-1999. COPD. 2005; 2: 35-41.
29. Sidney S, Sorel M, Quesenberry CP Jr, et al. COPD, and incident cardiovascular disease hospitalizations, and mortality: Kaiser Permanente Medical Care Program. Chest. 2005; 128: 2068-75.
30. Curkendall SM, Lanes S, de Luise C, et al. Chronic obstructive pulmonary disease severity, and cardiovascular outcomes. Eur J Epidemiol. 2006; 21: 803-13.
31. Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction, and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J. 2011; 32: 2365-75.
32. Yin L, Lensmar C, Ingelsson E, et al. Differential association of chronic obstructive pulmonary disease with myocardial infarction, and ischemic stroke in a nation-wide cohort. Int J Cardiol. 2014; 173: 601-3.
33. Rha SW, Li YJ, Chen KY, et al. Impact of chronic obstructive pulmonary disease on the clinical characteristics, and outcomes in propensity-matched patients with acute myocardial infarction. Am J Cardiol. 2009; 103: 36-37B.